NDC Package 0338-9593-10 Plasma-lyte 148 (ph 7.4)
Sodium Chloride,Sodium Gluconate,Sodium Acetate,Potassium Chloride,Magnesium Chloride - View Billable Units, 11-Digit Format, RxNorm
Package Information
Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.
- RxCUI: 801109 - magnesium chloride 0.00148 MEQ/mL / potassium chloride 0.00497 MEQ/mL / sodium acetate 0.027 MEQ/mL / sodium chloride 0.0899 MEQ/mL / sodium gluconate 5.02 MG/mL Injectable Solution
- RxCUI: 801109 - magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.00497 MEQ/ML / sodium acetate 0.027 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution
- RxCUI: 801109 - Magnesium Chloride 0.00148 MEQ/ML / K+ Chloride 0.00497 MEQ/ML / Sodium Acetate 0.027 MEQ/ML / NaCl 0.0899 MEQ/ML / Sodium gluconate 5.02 MG/ML Injectable Solution
- RxCUI: 801109 - Magnesium Chloride 0.00148 MEQ/ML / Pot Chloride 0.00497 MEQ/ML / Sodium Acetate 0.027 MEQ/ML / NaCl 0.0899 MEQ/ML / Sodium gluconate 5.02 MG/ML Injectable Solution
- RxCUI: 801357 - PLASMA-LYTE 148 Injectable Solution
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- 0338 - Baxter Healthcare Corporation
- 0338-9593 - Plasma-lyte 148 (ph 7.4)
- 0338-9593-10 - 10 BAG in 1 CARTON / 1000 mL in 1 BAG (0338-9593-01)
- 0338-9593 - Plasma-lyte 148 (ph 7.4)
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
Frequently Asked Questions
What is NDC 0338-9593-10?
The NDC Packaged Code 0338-9593-10 is assigned to a package of 10 bag in 1 carton / 1000 ml in 1 bag (0338-9593-01) of Plasma-lyte 148 (ph 7.4), a human prescription drug labeled by Baxter Healthcare Corporation. The product's dosage form is injection, solution and is administered via intravenous form.
Is NDC 0338-9593 included in the NDC Directory?
Yes, Plasma-lyte 148 (ph 7.4) with product code 0338-9593 is active and included in the NDC Directory. The product was first marketed by Baxter Healthcare Corporation on November 08, 2024 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.
What is the NDC billing unit for package 0338-9593-10?
The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.
What is the 11-digit format for NDC 0338-9593-10?
The 11-digit format is 00338959310. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.
This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:
| 10-Digit Format | 10-Digit Original Code | 11-Digit Format | 11-Digit Code |
|---|---|---|---|
| 4-4-2 | 0338-9593-10 | 5-4-2 | 00338-9593-10 |